Liraglutide Improves Zinc Signaling and Mitochondrial Function in Insulin-Resistant Cells | Research

The takeaway

Liraglutide modulated intracellular zinc release and improved mitochondrial bioenergetics in insulin-resistant hepatocyte models, revealing a novel mechanism through zinc-mitochondria crosstalk.

Zinc → mitochondria link
Liraglutide improves mitochondrial function through zinc signaling modulation — a previously unknown GLP-1 drug mechanism

What the researchers found

Liraglutide modulated zinc release and improved mitochondrial bioenergetics in insulin-resistant hepatocytes, revealing zinc-mitochondria crosstalk as a novel GLP-1 drug mechanism.

Why it matters

Understanding how GLP-1 drugs improve cellular energy production through zinc signaling reveals new therapeutic targets and explains metabolic benefits beyond glucose/appetite effects.

How the study worked

In vitro insulin-resistant hepatocyte models treated with liraglutide, with intracellular zinc dynamics measurement and mitochondrial bioenergetic profiling.

What this study cannot tell us

In vitro hepatocyte models. Cannot determine clinical significance of zinc modulation. Single GLP-1 drug tested.

How to read the evidence

In vitro mechanistic study. Novel finding requiring in vivo validation.

When this study was published

Published in 2025.

The bigger picture

Zinc-mitochondria crosstalk may be a fundamental mechanism linking metabolic disease, aging, and GLP-1 drug benefits.

Questions still open

Does zinc supplementation enhance GLP-1 drug effectiveness?
Is zinc-mitochondria crosstalk relevant in other tissues (muscle, brain)?
Could zinc status predict GLP-1 drug response?

Common questions

How does liraglutide improve cell energy?

This study found liraglutide modulates zinc levels inside cells, which in turn improves how mitochondria (cellular power plants) produce energy. This zinc-mitochondria connection is a newly discovered mechanism.

Should I take zinc with GLP-1 drugs?

This is too early to recommend. The study shows zinc plays a role in how GLP-1 drugs work at the cellular level, but whether zinc supplements would enhance drug effects needs further study.

Read the original research

Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.

Cardiovascular toxicology, 26(2), 22

View on PubMed ↗Publisher’s paper ↗

Citation

Hosseinpourshirazi, Fatemeh; Mendes, Umur D; Aksoy, Zeynep B; Aydos, Dunya; Sözer, Merve; Aljaser, Lubne; Gundogdu, Manolya; Sık, Suatnur; Tuncay, Erkan; Turan, Belma; Olgar, Yusuf. (2026). Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.. Cardiovascular toxicology, 26(2), 22. https://doi.org/10.1007/s12012-026-10095-x